查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
組織診斷市場、份額、規模、趨勢、行業分析報告：按產品、技術、疾病、應用、地區、細分市場預測，2024-2032
市場調查報告書
商品編碼
1421730

組織診斷市場、份額、規模、趨勢、行業分析報告：按產品、技術、疾病、應用、地區、細分市場預測，2024-2032

Tissue Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product ; By Technology; By Disease ; By End-Use; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，到 2032 年，全球組織診斷市場規模預計將達到 101.8 億美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

組織診斷在醫學領域發揮重要作用，可以透過分析組織樣本來診斷癌症和其他疾病。 在使用的各種技術中，蘇木精和伊紅染色 (H&E) 被廣泛認為是病理學家評估潛在癌症病例時的黃金標準。 癌症診斷和監測是組織診斷的主要用途，但它們也可用於診斷其他疾病。 該領域對個人化醫療寄予厚望，為不同類型的癌症提供量身定制的治療方法。

組織診斷可用於開發標靶治療並改善患者預後。 此外，它還有助於預防疾病復發。 例如，2023 年 1 月，國際癌症研究機構 (IARC) 發布了綜合數位指南《乳癌早期檢測圖集》。 它提供了臨床乳房檢查、診斷性乳房X光檢查、診斷性乳房超音波、細針抽吸細胞學和核心乳房活檢的逐步方法。

對個人化醫療的日益重視正在推動對基於組織的診斷測試的需求，以幫助選擇和監測標靶治療。 數位病理測試和自動化等技術進步正在提高組織診斷的效率和準確性。 此外，人們對多重檢測越來越感興趣，它可以同時分析單一組織樣本中的多個生物標記。 此外，產業參與者之間的夥伴關係和協作正在推動創新和全面解決方案的開發。 人工智慧和機器學習在組織診斷中的整合有望透過實現自動化分析和預測功能來徹底改變該領域。

組織診斷市場報告亮點

  • 消耗品業務預計將在預測期內保持最高成長。
  • 免疫組化領域將在 2022 年佔據最大的市場銷售份額，因為免疫組化可以以更高的特異性區分腫瘤類型。
  • 到 2022 年，醫院產業將佔據市場最大的銷售份額。 原因是，由於效率和可用性的提高，醫生正在採用組織診斷測試技術而不是傳統方法。
  • 得益於旨在降低癌症發病率的癌症預防和控制研究網絡等公共項目，北美在 2022 年佔據了最大的市場銷售份額。

目錄

第1章簡介

第 2 章執行摘要

第3章研究方法

第 4 章全球組織診斷市場洞察

  • 組織診斷 - 行業概況
  • 組織診斷市場動態
    • 推動者和機會
      • 影像技術的進步和診斷負擔能力的提高
      • 個人化治療與診斷的發展
    • 抑制因素和挑戰
      • 與研發和臨床試驗相關的高昂成本
  • 杵分析
  • 組織診斷產業的趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第5章全球組織診斷市場（按技術）

  • 主要調查結果
  • 簡介
  • 原位雜交
  • 初級染色和特殊染色
  • 免疫組織化學
  • 數位病理學
  • 其他

第 6 章全球組織診斷市場（按產品）

  • 主要調查結果
  • 簡介
  • 設備
  • 消耗品

第七章依疾病劃分的全球組織診斷市場

  • 主要調查結果
  • 簡介
  • 攝護腺癌
  • 乳癌
  • 肺癌
  • 皮膚癌
  • 其他

第 8 章全球組織診斷市場，依最終用途劃分

  • 主要調查結果
  • 簡介
  • 醫院
  • 研究
  • 合約研究組織
  • 製藥公司
  • 其他

第 9 章全球組織診斷市場（按地區）

  • 主要調查結果
  • 簡介
    • 2019-2032 年組織診斷市場評估，地區
  • 組織診斷市場 - 北美
    • 北美：組織診斷市場（按技術），2019-2032 年
    • 北美：組織診斷市場（依最終用途），2019-2032 年
    • 北美：組織診斷市場（按產品），2019-2032 年
    • 北美：組織診斷市場，依疾病分類，2019-2032 年
    • 組織診斷市場-美國
    • 組織診斷市場 - 加拿大
  • 組織診斷市場 - 歐洲
    • 歐洲：組織診斷市場（按技術），2019-2032 年
    • 歐洲：組織診斷市場（依最終用途），2019-2032 年
    • 歐洲：組織診斷市場（按產品），2019-2032 年
    • 歐洲：組織診斷市場，依疾病分類，2019-2032 年
    • 組織診斷市場 - 英國
    • 組織診斷市場 - 法國
    • 組織診斷市場-德國
    • 組織診斷市場-義大利
    • 組織診斷市場 - 西班牙
    • 組織診斷市場 - 荷蘭
    • 組織診斷市場-俄羅斯
  • 組織診斷市場 - 亞太地區
    • 亞太地區：組織診斷市場（按技術），2019-2032 年
    • 亞太地區：組織診斷市場（依最終用途），2019-2032 年
    • 亞太地區：組織診斷市場（按產品），2019-2032 年
    • 亞太地區：組織診斷市場（依疾病），2019-2032 年
    • 組織診斷市場—中國
    • 組織診斷市場-印度
    • 組織診斷市場—日本
    • 馬來西亞組織診斷市場
    • 組織診斷市場-印尼
    • 組織診斷市場—韓國
  • 組織診斷市場 - 中東/非洲
    • 中東和非洲：組織診斷市場（按技術），2019-2032 年
    • 中東和非洲：組織診斷市場（以最終用途），2019-2032 年
    • 中東和非洲：組織診斷市場（按產品），2019-2032 年
    • 中東和非洲：組織診斷市場（按疾病），2019-2032 年
    • 組織診斷市場 - 沙烏地阿拉伯
    • 組織診斷市場 - 南非
    • 組織診斷市場 - 以色列
    • 組織診斷市場 - 阿拉伯聯合大公國
  • 組織診斷市場 - 拉丁美洲
    • 拉丁美洲：組織診斷市場（按技術），2019-2032 年
    • 拉丁美洲：組織診斷市場（依最終用途），2019-2032 年
    • 拉丁美洲：組織診斷市場（按產品），2019-2032 年
    • 拉丁美洲：組織診斷市場，依疾病分類，2019-2032 年
    • 組織診斷市場 - 墨西哥
    • 組織診斷市場 - 巴西
    • 組織診斷市場 - 阿根廷

第10章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第11章公司簡介

  • Abbott
  • Agilent Technologies, Inc.
  • Bio SB
  • BioGenex
  • Becton, Dickinson and Company（BD）
  • Cell Signaling Technology, Inc.
  • Danaher
  • GE Healthcare
  • Histo-Line Laboratories
  • Hologic Inc
  • Merck KGAA
  • Metropolis Healthcare Limited
  • Roche
  • SAKURA FINETEK JAPAN CO., LTD
  • SLEE Medical GMBH
  • Thermo Fisher Scientific Inc.
Product Code: PM4060

The global tissue diagnostics market size is expected to reach USD 10.18 billion by 2032, according to a new study by Polaris Market Research. The report "Tissue Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Consumables); By Technology; By Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Skin Cancer, Others); By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Tissue diagnostics play a crucial role in the medical field, enabling the analysis of tissue samples to diagnose cancer and other disorders. Among the various techniques used, hematoxylin and eosin stain (H&E) is widely regarded as the gold standard by pathologists when evaluating potential cancer cases. While cancer diagnosis and monitoring are the primary applications of tissue diagnostics, they can also be utilized for diagnosing other diseases. This field holds great promise for personalized medicine, offering tailored treatment options for different types of cancers.

By leveraging tissue diagnostics, targeted therapies can be developed, improving patient outcomes. Furthermore, it aids in preventing disease relapses. For instance, In January 2023, The International Agency for Research on Cancer (IARC) introduced the Atlas of Breast Cancer Early Detection, a comprehensive digital guide. It provides a step-by-step approach to clinical breast examination, diagnostic mammography, diagnostic breast ultrasound, fine-needle aspiration cytology, and core breast biopsy.

A growing emphasis on personalized medicine has increased demand for tissue-based diagnostic tests that aid in targeted treatment selection and monitoring. Technological advancements, such as digital pathology and automation, are improving the efficiency and accuracy of tissue diagnostics. Additionally, a rising focus on multiplex assays enables the simultaneous analysis of multiple biomarkers in a single tissue sample. Furthermore, partnerships and collaborations between industry players drive innovation and comprehensive solutions development. Integrating artificial intelligence and machine learning in tissue diagnostics is poised to revolutionize the field by enabling automated analysis and predictive capabilities.

Tissue Diagnostics Market Report Highlights

  • Consumables segment is anticipated to hold the highest growth during the forecast period, due to these are the products are implemented for reliable and accurate tissue analysis.
  • Immunohistochemistry segment accounted for the largest revenue shares of the market in 2022, due to immunohistochemistry technique can be distinguished between tumor types with greater specificity.
  • Hospitals segment is holding the largest revenue shares of the market in 2022, due to physicians are implementing tissue diagnostics testing techniques over conventional methods due to its enhanced efficiency and utility.
  • North America holds the largest revenue shares of the market in 2022, due to public programs like the Cancer Prevention and Control Research Network, aiming to reduce cancer incidence.
  • The global key market players include: Abbott, Agilent Technologies, Inc., Bio SB, BioGenex, Becton, Dickinson and Company (BD), Cell Signaling Technology, Inc., Danaher, GE Healthcare, and others.

Polaris Market Research has segmented the Tissue Diagnostics market report based on product, technology, disease, end-use, and region:

Tissue Diagnostics, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Instruments
  • Consumables

Tissue Diagnostics, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

  • In-situ hybridization
  • Primary & Special Staining
  • Immunohistochemistry
  • Digital Pathology
  • Others

Tissue Diagnostics, Disease Outlook (Revenue - USD Billion, 2019 - 2032)

  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Skin Cancer
  • Others

Tissue Diagnostics, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Research Laboratories
  • Contract Research Organizations
  • Pharmaceutical Companies
  • Other

Tissue Diagnostics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Tissue Diagnostics Market Insights

  • 4.1. Tissue Diagnostics - Industry Snapshot
  • 4.2. Tissue Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in imaging techniques and improved diagnostics affordability
      • 4.2.1.2. Growth of personalized therapeutics and diagnostics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The high costs associated with R&D and clinical trials
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Tissue Diagnostics Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Tissue Diagnostics Market, by Technology

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • 5.3. In-situ hybridization
    • 5.3.1. Global Tissue Diagnostics Market, by In-situ hybridization, by Region, 2019-2032 (USD Billion)
  • 5.4. Primary & Special Staining
    • 5.4.1. Global Tissue Diagnostics Market, by Primary & Special Staining, by Region, 2019-2032 (USD Billion)
  • 5.5. Immunohistochemistry
    • 5.5.1. Global Tissue Diagnostics Market, by Immunohistochemistry, by Region, 2019-2032 (USD Billion)
  • 5.6. Digital Pathology
    • 5.6.1. Global Tissue Diagnostics Market, by Digital Pathology, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Tissue Diagnostics Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Tissue Diagnostics Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 6.3. Instruments
    • 6.3.1. Global Tissue Diagnostics Market, by Instruments, by Region, 2019-2032 (USD Billion)
  • 6.4. Consumables
    • 6.4.1. Global Tissue Diagnostics Market, by Consumables, by Region, 2019-2032 (USD Billion)

7. Global Tissue Diagnostics Market, by Disease

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • 7.3. Prostate Cancer
    • 7.3.1. Global Tissue Diagnostics Market, by Prostate Cancer, by Region, 2019-2032 (USD Billion)
  • 7.4. Breast Cancer
    • 7.4.1. Global Tissue Diagnostics Market, by Breast Cancer, by Region, 2019-2032 (USD Billion)
  • 7.5. Lung Cancer
    • 7.5.1. Global Tissue Diagnostics Market, by Lung Cancer, by Region, 2019-2032 (USD Billion)
  • 7.6. Skin Cancer
    • 7.6.1. Global Tissue Diagnostics Market, by Skin Cancer, by Region, 2019-2032 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Tissue Diagnostics Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Tissue Diagnostics Market, by End-Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Global Tissue Diagnostics Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 8.4. Research Laboratories
    • 8.4.1. Global Tissue Diagnostics Market, by Research Laboratories, by Region, 2019-2032 (USD Billion)
  • 8.3. Contract Research Organizations
    • 8.3.1. Global Tissue Diagnostics Market, by Contract Research Organizations, by Region, 2019-2032 (USD Billion)
  • 8.4. Pharmaceutical Companies
    • 8.4.1. Global Tissue Diagnostics Market, by Pharmaceutical Companies, by Region, 2019-2032 (USD Billion)
  • 8.3. Other
    • 8.3.1. Global Tissue Diagnostics Market, by Other, by Region, 2019-2032 (USD Billion)

9. Global Tissue Diagnostics Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Tissue Diagnostics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Tissue Diagnostics Market - North America
    • 9.3.1. North America: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
    • 9.3.2. North America: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
    • 9.3.3. North America: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 9.3.4. North America: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.3.5. Tissue Diagnostics Market - U.S.
      • 9.3.5.1. U.S.: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.3.6. Tissue Diagnostics Market - Canada
      • 9.3.6.1. Canada: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • 9.4. Tissue Diagnostics Market - Europe
    • 9.4.1. Europe: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.5. Tissue Diagnostics Market - UK
      • 9.4.5.1. UK: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.6. Tissue Diagnostics Market - France
      • 9.4.6.1. France: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.7. Tissue Diagnostics Market - Germany
      • 9.4.7.1. Germany: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.8. Tissue Diagnostics Market - Italy
      • 9.4.8.1. Italy: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.9. Tissue Diagnostics Market - Spain
      • 9.4.9.1. Spain: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.10. Tissue Diagnostics Market - Netherlands
      • 9.4.10.1. Netherlands: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.4.11. Tissue Diagnostics Market - Russia
      • 9.4.11.1. Russia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • 9.5. Tissue Diagnostics Market - Asia Pacific
    • 9.5.1. Asia Pacific: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.5. Tissue Diagnostics Market - China
      • 9.5.5.1. China: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.6. Tissue Diagnostics Market - India
      • 9.5.6.1. India: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.7. Tissue Diagnostics Market - Japan
      • 9.5.7.1. Japan: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.8. Tissue Diagnostics Market - Malaysia
      • 9.5.8.1. Malaysia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.9. Tissue Diagnostics Market - Indonesia
      • 9.5.9.1. Indonesia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.5.10. Tissue Diagnostics Market - South Korea
      • 9.5.10.1. South Korea: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • 9.6. Tissue Diagnostics Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.6.5. Tissue Diagnostics Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.6.6. Tissue Diagnostics Market - South Africa
      • 9.6.6.1. South Africa: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.6.7. Tissue Diagnostics Market - Israel
      • 9.6.7.1. Israel: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.6.8. Tissue Diagnostics Market - UAE
      • 9.6.8.1. UAE: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • 9.7. Tissue Diagnostics Market - Latin America
    • 9.7.1. Latin America: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.7.5. Tissue Diagnostics Market - Mexico
      • 9.7.5.1. Mexico: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.7.6. Tissue Diagnostics Market - Brazil
      • 9.7.6.1. Brazil: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
    • 9.7.7. Tissue Diagnostics Market - Argentina
      • 9.7.7.1. Argentina: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Abbott
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Agilent Technologies, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Bio SB
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. BioGenex
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Becton, Dickinson and Company (BD)
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Cell Signaling Technology, Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Danaher
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. GE Healthcare
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Histo-Line Laboratories
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Hologic Inc
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Merck KGAA
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Metropolis Healthcare Limited
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Roche
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. SAKURA FINETEK JAPAN CO., LTD
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. SLEE Medical GMBH
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
  • 11.16. Thermo Fisher Scientific Inc.
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Benchmarking
    • 11.16.4. Recent Development

List of Tables

  • Table 1 Global Tissue Diagnostics Market, by Technology, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Tissue Diagnostics Market, by Product, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Tissue Diagnostics Market, by Disease, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Tissue Diagnostics Market, by End-Use, by Region, 2019-2032 (USD Billion)
  • Table 5 Tissue Diagnostics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 7 North America: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 8 North America: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 9 North America: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 10 U.S.: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 11 U.S.: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 12 U.S.: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 13 U.S.: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 14 Canada: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 15 Canada: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 16 Canada: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 17 Canada: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 18 Europe: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 19 Europe: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 20 Europe: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 21 Europe: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 22 Germany: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 23 Germany: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Germany: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 25 Germany: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 26 France: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 27 France: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 28 France: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 29 France: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 30 UK: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 31 UK: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 32 UK: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 33 UK: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 34 Italy: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 35 Italy: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Italy: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 37 Italy: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 42 Spain: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 43 Spain: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 44 Spain: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 45 Spain: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 46 Russia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 47 Russia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 48 Russia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 49 Russia: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 54 China: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 55 China: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 56 China: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 57 China: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 58 Japan: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 59 Japan: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 60 Japan: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 61 Japan: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 62 India: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 63 India: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 64 India: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 65 India: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 74 South Korea: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 75 South Korea: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 76 South Korea: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 77 South Korea: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 78 Latin America: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 79 Latin America: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 80 Latin America: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 81 Latin America: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 82 Brazil: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 83 Brazil: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 84 Brazil: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 85 Brazil: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 86 Mexico: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 87 Mexico: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 88 Mexico: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 89 Mexico: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 90 Argentina: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 91 Argentina: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 92 Argentina: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 93 Argentina: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 98 UAE: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 99 UAE: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 100 UAE: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 101 UAE: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 106 South Africa: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 107 South Africa: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 108 South Africa: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 109 South Africa: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)
  • Table 110 Israel: Tissue Diagnostics Market, by Technology, 2019-2032 (USD Billion)
  • Table 111 Israel: Tissue Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 112 Israel: Tissue Diagnostics Market, by Disease, 2019-2032 (USD Billion)
  • Table 113 Israel: Tissue Diagnostics Market, by End-Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Tissue Diagnostics Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up End-Use
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Technology
  • Figure 7. Global Tissue Diagnostics Market, by Technology, 2021 & 2030 (USD Billion)
  • Figure 8. Market by End-Use
  • Figure 9. Global Tissue Diagnostics Market, by End-Use, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Product
  • Figure 11. Global Tissue Diagnostics Market, by Product, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Disease
  • Figure 13. Global Tissue Diagnostics Market, by Disease, 2021 & 2030 (USD Billion)